Please login to the form below

Not currently logged in


This page shows the latest reslizumab news and features for those working in and with pharma, biotech and healthcare.

AZ gets EMA green light for severe asthma drug Fasenra

AZ gets EMA green light for severe asthma drug Fasenra

Fasenra (benralizumab) is the third IL-5-targetting drug approved for market after GlaxoSmithKline’s Nucala (mepolizumab) and Teva’s Cinqaero (reslizumab) and according to AZ, it is the first biologic

Latest news

More from news
Approximately 5 fully matching, plus 24 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...